Table 2.
Patient characteristics according to NLR or LMR
| NLR < 2.9
(n = 21) |
NLR ≥ 2.9
(n = 14) |
p | LMR > 2.4
(n = 25) |
LMR ≤ 2.4
(n = 10) |
p | |||
| Age | 67.9 ± 13.5 | 58.6 ± 11.6 | 0.043 | 66.3 ± 13.0 | 59.0 ± 13.6 | 0.146 | ||
| Gender | 0.728 | 1.000 | ||||||
| Male | 11 | 9 | 14 | 6 | ||||
| Female | 10 | 5 | 11 | 4 | ||||
| T | 0.028 | 0.686 | ||||||
| T1 + T2 | 9 | 1 | 8 | 2 | ||||
| T3 + T4 | 12 | 13 | 17 | 8 | ||||
| N | 0.483 | 1.000 | ||||||
| negative | 14 | 7 | 15 | 6 | ||||
| positive | 7 | 7 | 10 | 4 | ||||
| Stage | 0.007 | 0.134 | ||||||
| ≤ IIA | 13 | 2 | 13 | 2 | ||||
| > IIA | 8 | 12 | 12 | 8 | ||||
| Ly | 0.461 | 1.000 | ||||||
| 0 | 8 | 3 | 8 | 3 | ||||
| 1 | 13 | 11 | 17 | 7 | ||||
| V | 1.000 | 0.393 | ||||||
| 0 | 5 | 4 | 5 | 4 | ||||
| 1 | 16 | 10 | 20 | 6 | ||||
| Histology | 0.288 | 0.123 | ||||||
| Well | 6 | 7 | 7 | 6 | ||||
| Moderate | 15 | 7 | 18 | 4 | ||||
| CRT | 0.221 | 0.027 | ||||||
| − | 18 | 9 | 22 | 5 | ||||
| + | 3 | 5 | 3 | 5 | ||||
| Adj | 0.006 | 0.146 | ||||||
| − | 15 | 3 | 15 | 3 | ||||
| + | 6 | 11 | 10 | 7 |
NLR: neutrophil-to-lymphocyte ratio, LMR: lymphocyte-to-monocyte ratio, Ly: lymphatic vessel invasion, V: microscopic vascular invasion, Well: well-differentiated adenocarcinoma, Moderate: moderately-differentiated adenocarcinoma, CRT: preoperative chemoradiation therapy, Adj: adjuvant chemotherapy.